» Articles » PMID: 34462679

Stage 4 Takayasu Retinopathy With Persistent Neovascularization

Overview
Journal Cureus
Date 2021 Aug 31
PMID 34462679
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Takayasu arteritis is a chronic, progressive, autoimmune, granulomatous, medium-to-large vessel-panarteritis. It may cause chronic ocular ischaemia that may be refractory to treatment. We report a case of stage 4 Takayasu retinopathy resistant to conventional treatments. The patient was a 22-year-old woman who was diagnosed with Takayasu arteritis when she first presented with claudication while chewing and swallowing for one month. The patient was found to be hypertensive, with a significant systolic blood pressure difference between the arms and non-palpable bilateral brachial and radial artery pulses. Angiogram imaging revealed abnormalities involving the left subclavian, bilateral common carotid and left internal carotid arteries. She was referred to the ophthalmology clinic, as she experienced bilateral recurrent transient visual loss six months after the diagnosis. Dilated fundus examination showed bilateral stage 2 Takayasu retinopathy, evidenced by the presence of dilated retinal veins with microaneurysms. Her eyes progressed to stage 4 Takayasu retinopathy with proliferative retinopathy within one year of immunomodulatory therapy, largely due to poor compliance. No signs of regression were observed after completion of bilateral pan-retinal photocoagulation (PRP) with ongoing immunosuppressive treatment.

Citing Articles

Posterior segment manifestations of Takayasu arteritis: A narrative review.

Sharma U, Rishi E, Rishi P, Gupta V, Raman R Indian J Ophthalmol. 2024; 72(5):637-647.

PMID: 38648432 PMC: 11168552. DOI: 10.4103/IJO.IJO_1346_23.


Ocular Manifestations of Takayasu's Arteritis-A Case-Based Systematic Review and Meta-Analysis.

Szydelko-Pasko U, Przezdziecka-Dolyk J, Nowak L, Malyszczak A, Misiuk-Hojlo M J Clin Med. 2023; 12(11).

PMID: 37297942 PMC: 10253919. DOI: 10.3390/jcm12113745.


Therapeutic Management of Ocular Ischemia in Takayasu's Arteritis: A Case-Based Systematic Review.

Zeng Y, Duan J, Ge G, Zhang M Front Immunol. 2022; 12:791278.

PMID: 35095866 PMC: 8795594. DOI: 10.3389/fimmu.2021.791278.

References
1.
Alibaz-Oner F, Aydin S, Direskeneli H . Recent advances in Takayasu's arteritis. Eur J Rheumatol. 2016; 2(1):24-30. PMC: 5047239. DOI: 10.5152/eurjrheumatol.2015.0060. View

2.
Pallangyo P, Epafra E, Nicholaus P, Lyimo F, Kazahura P, Janabi M . Bilateral ocular ischemia-induced blindness as a presenting manifestation of Takayasu arteritis: a case report. J Med Case Rep. 2017; 11(1):153. PMC: 5466759. DOI: 10.1186/s13256-017-1330-3. View

3.
Gong Q, Qian T, Chen F, Xu X, Wang W . A case of anti-VEGF therapy application in Takayasu arteries with retinopathy. Am J Ophthalmol Case Rep. 2020; 19:100706. PMC: 7474339. DOI: 10.1016/j.ajoc.2020.100706. View

4.
Peter J, David S, Joseph G, Horo S, Danda D . Hypoperfusive and hypertensive ocular manifestations in Takayasu arteritis. Clin Ophthalmol. 2010; 4:1173-6. PMC: 2964953. DOI: 10.2147/OPTH.S12331. View

5.
Arend W, Michel B, Bloch D, Hunder G, Calabrese L, Edworthy S . The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990; 33(8):1129-34. DOI: 10.1002/art.1780330811. View